Sexual dimorphism of the immune system predicts clinical outcomes in glioblastoma immunotherapy: A systematic review and meta-analysis.

Shireman, Jack M; Ammanuel, Simon; Eickhoff, Jens C; Dey, Mahua

Shireman, Jack M; Ammanuel, Simon; Eickhoff, Jens C; Dey, Mahua.

Afiliação

Shireman JM; Department of Neurosurgery, University of Wisconsin School of Medicine and Public Health, UW Carbone Cancer Center, Madison, Wisconsin, USA.
Ammanuel S; Department of Neurosurgery, University of Wisconsin School of Medicine and Public Health, UW Carbone Cancer Center, Madison, Wisconsin, USA.
Eickhoff JC; Department of Biostatistics and Medical Informatics, University of Wisconsin School of Medicine and Public Health, Madison, Wisconsin, USA.
Dey M; Department of Neurosurgery, University of Wisconsin School of Medicine and Public Health, UW Carbone Cancer Center, Madison, Wisconsin, USA.

Neurooncol Adv ; 4(1): vdac082, 2022.

Article em En | MEDLINE | ID: mdl-35821678

Palavras-chave

glioblastoma; glioma; immunotherapy; sexual dimorphism

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Idioma: En Revista: Neurooncol Adv Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google